全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Results of noninvasive ventilation in very old patients

DOI: 10.1186/2110-5820-2-5

Full-Text   Cite this paper   Add to My Lib

Abstract:

Prospective cohort of all patients admitted to the medical ICU of a tertiary hospital during a 2-year period and managed using NIV. Characteristics of patients, context of NIV, and treatment intensity were compared for very old and younger patients. Six-month survival and functional status were assessed in very old patients.During the study period, 1,019 patients needed ventilatory support and 376 (37%) received NIV. Among them, 163 (16%) very old patients received ventilatory support with 60% of them managed using NIV compared with 32% of younger patients (p < 0.0001). Very old patients received NIV more frequently with DNI than in younger patients (40% vs. 8%). Such cases were associated with high mortality for both very old and younger patients. Hospital mortality was higher in very old than in younger patients but did not differ when NIV was used for cardiogenic pulmonary edema or acute-on-chronic respiratory failure (20% vs. 15%) and in postextubation (15% vs. 17%) out of a context of DNI. Six-month mortality was 51% in very old patients, 67% for DNI patients, and 77% in case of NIV failure and endotracheal intubation. Of the 30 hospital survivors, 22 lived at home and 13 remained independent for activities of daily living.Very old patients managed using NIV have an overall satisfactory 6-month survival and functional status, except for endotracheal intubation after NIV failure.The use of noninvasive ventilation (NIV) as first-line supportive therapy for acute respiratory failure (ARF) is increasing in the ICU. The reduced invasiveness of this technique in selected populations of critically ill patients leads to better outcomes than with endotracheal intubation. NIV reduces the need for intubation and decreases mortality during acute-on-chronic respiratory failure (AOC), cardiogenic pulmonary edema (CPE), and de novo ARF in immunocompromised patients [1-6]. Recently, NIV has been proposed for the prevention of postextubation ARF for at-risk patients, with promi

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413